Eidos Therapeutics
Aug 07, 2020
Unfolding The Folds Of Transthyretin
The Hereditary Transthyretin Amyloidosis (hATTR) Market size in the 7MM was estimated to be USD 306.9 Million in 2017 and is anticipated to grow further in the forecast period 2020-30 owing to recent approvals and pipeline therapies.Among the 7MM geographies, the US accounted for the 54% share of the total hATTR ma...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
